A randomized, double‐blind, placebo‐controlled, parallel‐group, enriched‐design study of nabiximols * (Sativex®), as add‐on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotná, J. Mareš, S. Ratcliffe, I. Nováková +13 more

